Roche's Spark sues gene therapy rival bluebird for using 'spark' in its marketing campaigns

Roche’s Spark Therapeutics and fellow biotech bluebird bio are both developing gene therapies for blood disorders. Now, the two have found themselves in a legal battle that’s not about their treatments or patents, but, instead, trademarks.